Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04508205
Status:
COMPLETED
Last Update Posted:
2020-08-12
First Post:
2020-08-02
Brief Title:
CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes
Sponsor:
CAGE Bio Inc
Organization:
CAGE Bio Inc
Study Overview
Official Title:
Effectiveness of CGB-400 Cosmetic for the Reduction of Facial Redness and Bumps and Blemishes
Status:
COMPLETED
Status Verified Date:
2020-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Open-label multicenter study using CGB-400 Gel to reduce facial redness bumps and blemishes
Detailed Description:
This is a Open-label multicenter study to evaluate the ability of CGB-400 Gel to reduce facial redness and bumpsblemishes typically associated with rosacea Approximately 25 subjects will be enrolled
Subjects will receive study treatment for 12 weeks and attend a total of 5 study visits ie BL W2 W4 W8 W12
Subjects will receive study treatment for 12 weeks and attend a total of 5 study visits ie BL W2 W4 W8 W12
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None